Background
Increasing evidence suggests that interplay between immune cells and tumor cells exerts a major influence on oral tumor development and progression (Sahingur and Yeudall 2015) . Furthermore, recent "Cancer Immunoediting" concept provided insights that immune system has both immune surveillance and tumor promotion effects during the cancer development (Dunn et al. 2004; Schreiber et al. 2011) . In recent years, with the rapid development of molecular biology and immunology and the multidisciplinary
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+ T cells were significantly increased in advanced tumor stage, large tumor size and positive lymph nodes metastasis, compared to that in early groups. The accumulation of CD3 + CD4 + T cells were significantly increased in OSCC patients received 2 cycles CT and radical operation. Moreover, the accumulation of CD3 +
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+ B cells was related with radical operation in patients with OSCC. This study indicate that CD4 + T cells have opposing roles in OSCC progression and outcomes, which provides new insights relevant for the development of effective cancer immunotherapeutic approaches. 2 cycles TP regime chemotherapy and radical therapy may contribute to increase thecross integration, achievements have been made in the research of mutual regulation among immunological cells in tumor tissues (de Cos Escuin 2014; Liu et al. 2014) . Of the examination indexes for diagnosing the development, progression and prognosis of tumors, the detection of lymphocyte subgroups in peripheral blood is the most popular one in clinic (Liu et al. 2014; Jozwik et al. 2015) . It is established that an effective anti-tumor immune response requires the involvement of both CD4
+ and CD8 + T cells (Dunn et al. 2004; Schreiber et al. 2011 for pT3 and pT4 tumors, in comparison with pT2 carcinomas. These studies were similar with our present study (Starska et al. 2011a, b) . However, few studies were focused on the dynamic correlation between circulating lymphocyte subsets and different treatments in patients with oral squamous cell carcinoma (OSCC). Furthermore, the influence of chemotherapy (CT) and radical operation on circulating lymphocyte subsets of patients with OSCC remains unclear (Lau et al. 2007; Hsu et al. 2010 ). In the current study, the correlations between circulating immune subsets and pre-and post-treatment as well as the clinical characteristics were investigated in OSCC patients.
Methods

Patients
The study protocol was approved by the ethical committee of the Sichuan Cancer Hospital, China and was performed in accordance with the ethical standards laid down in the 
Immune subset measurement
Before treatment and 7 days after 2 cycles CT or radical operation, analysis of total lymphocytes and subsets was performed on whole blood samples (100 μL; 5 × 10 
Statistical analysis
Data are expressed as mean ± standard deviation (SD). The significance of difference between groups was determined by paired or unpaired two-tailed Student's t test or the one-way analysis of Variance (ANOVA). Difference was considered significant for p values less than 0.05.
Results
The clinical data
Patients' age ranged from 23 to 77 years (median 58.8), with 21 cases belonging to the >60 age group, accounting for 48.8 % of all patients. The locations of primary tumor were tongue, buccal, and the floor of mouth, respectively. There were 34 male and 9 female subjects. The size of the primary tumor was 1.5-6.0 cm (median 4.5). According to the seventh edition of the TNM classification, 17 cases were clinically classified as T 1-2 and 26 cases were clinically classified as T 3-4 . In addition, 19 cases were clinically classified as N 0 and 24 cases were clinically classified as N 1-3 . Only two cases had lung and bone metastasis. The primary diagnosis was performed by incisional biopsy. 21 were pathologically classified as well differentiated OSCC, 14 cases as intermediate differentiated OSCC, and 8 cases as poor differentiated OSCC. Clinical data of all cases are summarized in Table 1 . with no treatment in comparison with the 1 week after 1 cycle chemotherapy. But for patients with T 1-2 tumors received 2 cycles CT and radical operation, the percentage of CD3 + CD4 + T cells distribution was significantly increased, compared to that with no treatment and 1 week after 1 cycle CT (P < 0.0001) (Fig. 2a) . Moreover, there was no difference in patients with no treatment and 1 week after 1 cycle CT, and between 1 week after 2 cycles CT and post-operation. For CD3 + CD8 + T cells distribution, we observed that the T cells distribution was significantly decreased in patients with T 1-2 received 2 cycles CT or radical operation, compared to the patients with T 1-2 received no treatment or 1 cycle CT (P < 0.0001). Interestingly, CD3 + CD8 + T cells seems to be increased in patients with T 1-2 received 1 cycle CT, compared to that received no treatment (Fig. 2b) . We also analyzed the CD3 (Fig. 2c) . There seems to be no difference for CD3
Accumulation of CD3
+ NK cells distribution in all four time points (Fig. 2d ).
Almost the same tendency was observed in OSCC patients with T 3-4 tumor size. For patients with T 3-4 tumors received 2 cycles CT and radical operation, the percentage of CD3 + CD4 + T cells distribution was significantly increased, compared to the time points of no treatment and 1 cycle CT (P < 0.0001) (Fig. 2e) . Two-cycles CT and radical operation significantly decreased the percentage of CD3 + CD8 + T cells, compared to the time points of no treatment or 1 cycle CT (p < 0.0001) (Fig. 2f ) . The radical operation is the only time point to increase the distribution of CD3 − CD19 + B cells in comparison with the other three time points (p < 0.05) (Fig. 2g) . The distribution of CD3
NK cells was still no change in all four time points (Fig. 2h) . 
Dynamic distributions of CD4
CD4
+ T cells distribution was significantly increased in OSCC patients received 2 cycles CT and radical operation, compared to that received no treatment and 1 cycle CT (P < 0.0001) (Fig. 3a ). There were also no differences between the patients received no treatment and 1 cycle CT, and between the patients received 2 cycles CT and radical operation. The percentage of CD3 
CD19
+ T cells in the OSCC patients with T 3-4 size of primary tumor received different treatments; h the accumulation of CD3 − CD16 + CD56 + NK cells in the OSCC patients with T 3-4 size of primary tumor received different treatments. Error bars indicate mean ± SD, *P < 0.05, **P < 0.0001 significantly decreased in OSCC patients with no lymph nodes metastasis received 2 cycles CT and radical operation, compared to that received no treatment and 1 cycle CT (Fig. 3b) . The OSCC patients with no lymph nodes metastasis demonstrated that the CD3 −
+ B cells distribution significantly increased in time point of post-operation, compared to the other three time points (p < 0.0001) (Fig. 3c ). There was also no difference distribution of CD3
cells among four time points in
OSCC patients with no lymph nodes metastasis (Fig. 3d) . We also analyzed the percentage of four lymphocyte subtypes distribution in OSCC patients with N 1-3 lymph nodes metastasis received different treatments. The results demonstrated that the CD3 + CD4 + T cells distribution was significantly increased in patients with N 1-3 received 2 cycles CT and radical operation, compared to that received no treatment and 1 cycle CT (p < 0.0001) (Fig. 3e) . Interestingly, after 1 cycle CT, the CD3 in patients with N 1-3 received radical operation, compared to that received 2 cycles CT (P < 0.05), 1 cycle CT (p < 0.0001), and no treatment (p < 0.0001) (Fig. 3g) . There was no difference for CD3 − CD16 + CD56 + NK cells distribution in patients with N 1-3 in all four time points (Fig. 3h) . 
Dynamic distributions of CD4
CD4
+ T cells distribution was significantly increased for patients received 2 cycles CT and radical operation, compared to the that received no treatment and 1 cycle CT (P < 0.0001, p < 0.05, respectively) (Fig. 4a) . Two-cycle CT and radical operation significantly decreased the percentage of CD3 + CD8 + T cells, compared to the time points of no treatment or 1 cycle CT (p < 0.0001) (Fig. 4b) . The radical operation is the only time point to increase the distribution of CD3 
CD16
+ CD56 + NK cells in the OSCC patients with N 1-3 received different treatments. Error bars indicate mean ± SD, *P < 0.05, **P < 0.0001 T cells distribution in these patients received different treatments as those patients with intermediate differentiated tumors (Fig. 4e) . Moreover, two-cycle CT and radical operation significantly decreased the percentage of CD3 +
CD8
+ T cells, compared to the time points of no treatment or 1 cycle CT (p < 0.0001). However, 1 cycle CT seems to be increased the percentage of CD3 + CD8 + T cells, compared to the patients received no treatment (Fig. 4f ) . There was significant difference of CD3 − CD19 + B cells between patients with intermediate differentiated tumors received radical operation and that received no treatment, and between patients with intermediate differentiated tumors received radical operation and that received 1 cycle CT (Fig. 4g) . The distribution of CD3
+ NK cells was still no change in all four time points (Fig. 4h) . At last, we analyzed that the CD4 + , CD8 + T cells, CD19 + B cells, and CD56 + NK cells distribution using flow cytometer in OSCC patients with poor differentiated tumors received different treatments. The percentage of CD3 + CD4 + T cells distribution was significantly increased in patients received 1cycle CT, 2 cycles CT and radical operation, compared to the time points of no treatment (P < 0.0001) (Fig. 4i) . The percentage of CD3
T cells distribution was also significantly decreased in patients with poor differentiated tumors received 1 cycle CT (p < 0.0001), 2 cycles CT (p < 0.05), and radical operation (p < 0.0001), compared to that patients received no treatment. Moreover, the radical operation significantly increased the distribution of CD3 − CD19 + B cells in patients with poor differentiated tumors, compared to that received no treatment and 1 cycle CT (Fig. 4j) . However, 2 cycles CT seems to be decreased the distribution of CD3
cells in patients with poor differentiated tumors, compared to that received 1 cycle CT and radical operation (Fig. 4k) . The distribution of CD3 − CD16 + CD56 + NK cells was still no change in all four time points (Fig. 4l) .
Association of CD4 + /CD8 + ratio with OSCC patients received different treatments
To evaluate the effect of different treatments on patients with OSCC, we also analyze the CD4 + /CD8 + ratio in all OSCC patients received no treatment, 1 cycle CT, 2 cycles CT, and radical operation. The 2 cycles CT and radical operation indeed increased the CD4 + /CD8 + ratio in OSCC patients, compared to that received no treatment or 1 cycle CT (P < 0.0001). There was no significant difference between patients received no treatment and patients received 1 cycle CT, between patients received 2 cycles CT and patients received radical operation (Fig. 5) . These data suggested that the 2 cycles CT and radical operation treatment may be essential to increase the effect of treatment for the patients with OSCC.
Discussion
Kuhn et al. reported that abnormal T lymphocyte subgroups were found in peripheral blood, marked by decreased CD3 to be decreased in early group (T 1-2 /N 0 ), compared to that in advanced group (T 3-4 / N 1-3 ). However, except for group between ≤40 age group and ≥60 age group in comparison with 40-60 age group, there were no significant differences in the expression of CD3 + CD4 + and CD3 + CD8 + in OSCC patients with different pathological patterns, genders, and locations. Accumulating research findings suggested that there are multiple antitumor T cell clones in the peripheral blood of patients with lymphoma, but these T lymphocytes fail to retain effective antitumor properties (Yin et al. 2010 (Yin et al. , 2011 . Interestingly, Yin et al. showed that imbalance T-lymphocyte subsets occurs in patients with lymphoma during different chemotherapy stages, and these T-lymphocyte subsets gradually return to normal by 3 months after chemotherapy (Yin et al. 2014) . Given the poor prognosis of OSCC, the patients with OSCC (T 2-4 /N 1-3 ) received 2 cycles TP regime chemotherapy and radical operation, including extensive resection of the primary tumor, partial 
/CD8
+ ratio in OSCC patients received different treatments. Error bars indicate mean ± SD, **P < 0.0001 resection of maxillary/mandible, and functional neck dissection (Level I-V). To evaluate the dynamic effect of chemotherapy or operation on patients with OSCC, the lymphocytes subgroups were analyzed using flow cytometer. Interesting, 2 cycles TP regime chemotherapy and radical operation indeed significantly increased the expression of CD3 +
CD4
+ T cells and decreased the expression of CD3 + CD8 + T cells in almost all OSCC patients. The results suggested that the 2 cycles CT and radical operation were essential to improve the prognosis of OSCC patients. It is suggested that CD4 +
/CD8
+ ratio is crucial to be kept in a dynamic balance, in terms of maintaining the immunological function stable (Dou et al. 2013) . The ratio decreased is reported to link with a low immunological function (Erdem et al. 2012; Nugroho et al. 2012) . In this study, The patients with OSCC received 2 cycles CT or radical operation had a significantly higher level of CD4 +
+ ratio compared with that received no treatment or 1 cycle CT. NK cell is also designated as natural killer cells. NK cell could directly destroy tumor cells, and reduced level of NK cell will lead to decline of immunological function (Wang et al. 2013 (Tredan et al. 2013; Iriyama et al. 2013) . The high percentage of circulating CD19 + B cells alone correlated positively with better PFS of nasopharyngeal carcinoma (Xu et al. 2014 ). In our study, the expression of CD19 + B cells were only increased in OSCC patients received radical operation with different T stage, nodal status and pathological grading. There is no relationship between 2 cycles TP regime chemotherapy and the expression of CD19 + B cells. The mechanism need to be further explored.
Conclusion
In this study, the expression of CD4 + T cells were significantly increased in advanced tumor stage, large tumor size and positive lymph nodes metastasis, compared to that in early group. 2 cycles TP regime chemotherapy and radical therapy may be essential to increase the effects of anti-tumor immunity on patients with OSCC. However, the positive correlation between circulating CD19 + B cells and radical operation in patients with OSCC still need to be further explored in future study. The analysis of lymphocyte subgroups in peripheral blood detected by flow cytometry suggested that the lymphocyte subgroups may be the prognostic factor of OSCC.
